FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to molecular biology, virology, genetic engineering, biotechnology and veterinary science. What is presented is a recombinant vaccine containing a recombinant virus and pharmaceutically acceptable carrier, adjuvant or excipient, wherein the recombinant virus is inactivated and contained in the vaccine in the form of the viral vector having an introduced exogenous nucleotide sequence which codes an antigen of the disease, wherein the virus is inactivated by physical and chemical methods; the vaccine is effective against at least the above disease related to the above antigen.
EFFECT: invention can be used for vaccination in veterinary science.
23 cl, 11 dwg, 8 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT NEWCASTLE DISEASE VIRUS EXPRESSING H5 HEMAGGLUTININ OF AVIAN INFLUENZA VIRUS | 2007 |
|
RU2441070C2 |
| VECTORS OF RECOMBINANT VIRUSES OF Mononegavirales ORDER | 2007 |
|
RU2435857C2 |
| RECOMBINANT VECTORS EXPRESSING AVIAN INFLUENZA VIRUS ANTIGENS AND APPLICATIONS THEREOF | 2017 |
|
RU2761869C2 |
| STRAIN OF AVIAN INFLUENZA A VIRUS (H5N2) GKV N 2340 FOR INFLUENZA INFECTION MODELLING | 1999 |
|
RU2163637C1 |
| METHOD TO PRODUCE FLU VIRUS | 2008 |
|
RU2484136C2 |
| IMMUNOGENIC COMPOSITION AGAINST SUBTYPE H5 AVIAN FLU VIRUS | 2019 |
|
RU2809084C2 |
| NEW PROTEINS H5, MOLECULES OF NUCLEIC ACIDS THAT CODE THEM AND VECTORS, AND THEIR APPLICATION IN MEDICINE | 2007 |
|
RU2479589C2 |
| UNIVERSAL AVIAN INFLUENZA VIRUS VACCINE | 2007 |
|
RU2358981C2 |
| BROAD-SPECTRUM M2 PROTEIN ECTODOMAIN AVIAN INFLUENZA TYPE A VACCINE | 2014 |
|
RU2571944C1 |
| RECOMBINANT VACCINE AGAINST AVIAN FLU AND APPLICATION THEREOF | 2009 |
|
RU2559527C2 |
